Mhd Hussam Al Jandali, MD
Critical Care Medicine · Detroit, MINPI 1063831758
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.5% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $608, 6.3 times the $96 reported in 2019.
Across 54 payments — averaging $27.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Calliditas Therapeutics US Inc.$263
- Amgen$168
- Bayer$160
- Vantive US Healthcare LLC$147
- Otsuka America Pharmaceutical, Inc.$142
- Travere Therapeutics, Inc.$96
- plus $505 from 13 others
What the payments were for
- Food & beverage$1,39995%
- Education$815%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Calliditas Therapeutics US Inc. | 10 | $263 |
| Amgen | 5 | $168 |
| Bayer | 3 | $160 |
| Vantive US Healthcare LLC | 4 | $147 |
| Otsuka America Pharmaceutical, Inc. | 3 | $142 |
| Travere Therapeutics, Inc. | 4 | $96 |
| OPKO Pharmaceuticals, LLC | 4 | $81 |
| Novo Nordisk | 3 | $70 |
| Novartis | 3 | $70 |
| Ardelyx, Inc. | 3 | $63 |
| Lilly USA, LLC | 3 | $52 |
| Alnylam Pharmaceuticals Inc. | 2 | $39 |
| UCB, Inc. | 1 | $22 |
| AstraZeneca | 1 | $20 |
| Pfizer | 1 | $19 |
| Scpharmaceuticals Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Sanofi | 1 | $17 |
| Gilead | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$123
How this compares
$1,480 in reported general payments places this provider in the 75th percentile of 177 critical care medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Detroit
- Angel Peralta-AvilaDetroit$147K
- Amin PashaDetroit$8K
- Xavier Fonseca FuentesDetroit$4K
- Domingo Franco PalaciosDetroit$2K
- William PeruzziDetroit$2K
- Sai KattaDetroit$1K
- Christine AchoDetroit$918
- Moumen AsbahiTroy$81K
- Mujahed AbbasLansing$28K
- Abdulrazak AlchakakiSouthfield$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.